|
Scl 70 (N=41) |
Scl 70 (N=41) |
Scl 70 (N=41) |
ACA (N=27) |
ACA
(N=27) |
ACA (N=27) |
RNAPIII (N=15) |
RNAPIII (N=15) |
RNAPIII
(N=15) |
|
Single
n=28
|
Multiple
n=13
|
p
|
Single
n=16
|
Multiple
n=11
|
p
|
Single
n=6
|
Multiple
n=9
|
p
|
lcSSc |
9 (32.1%) |
6 (46.2%) |
0.386 |
16 (100%) |
11 (100%) |
NA |
2 (33.3%) |
3 (33.3%) |
1.000 |
Female |
27 (96.4%) |
11 (84.6%) |
0.176 |
15 (93.8%) |
11 (100%) |
1.000 |
4 (66.7%) |
7 (77.8) |
0.634 |
ILD |
17 (60.7%) |
7 (53.8%) |
0.678 |
0 |
1 (9.1%) |
0.407 |
4
(66.7%) |
5 (55.6) |
0.667 |
PAH |
1 (3.6%) |
0 |
0.490 |
0 |
0 |
NA |
1 (16.7%) |
1 (11.1%) |
0.756 |
Malignancy |
0 |
0 |
NA |
0 |
0 |
NA |
2 (33.3%) |
0 |
0.143 |
DU |
2 (7.1%) |
2 (15.1%) |
0.579 |
0 |
4 (36.4%) |
0.019 |
1
(16.7%) |
1 (11.1%) |
0.756 |
GIS |
15 (53.6%) |
9 (69.2%) |
0.499 |
8 (50%) |
7 (63.6%) |
0.696 |
4 (66.7%) |
7 (77.8%) |
0.634 |
Overlap |
4 (14.3%) |
1 (7.7%) |
1.000 |
7 (43.8%) |
4 (36.4%) |
0.508 |
0 |
1 (11.1%) |
1.000 |
Age |
47.9±12.9 |
44.8±12.6 |
0.792 |
51.5±10.2 |
48.9±10.7 |
1.000 |
60.2±9.9 |
52.1±5.9 |
0.088 |
Disease duration |
2±1.5 |
2.1±1.5 |
0.810 |
1.9±1.1 |
2.1±1.8 |
0.809 |
3±1.3 |
2.3±1.8 |
0.328 |
mRSS |
13.9±9.3 |
15.2±15.5 |
0.690 |
6.6±5.4 |
6.3±5.1 |
0.942 |
14.5±12.6 |
24.3±13.9 |
0.145 |